Blog | HemaCare

CAR T Cells, Little Steps, Huge Progress

Oct 14, 2015 1:00:51 PM / by Daisy posted in Cancer Immunology, CAR-T, clinical trial, CTL019, leukemia, research


Therapeutic CAR T cells administered to leukemia patients in a clinical trial offer long remissions associated with T cells that persist out to at least 4 years

Read More

CAR T Cells: Yes, Results are “Incredible” for Leukemia Clinical Trial

Feb 4, 2015 1:00:10 PM / by Daisy posted in acute lymphoblastic leukemia, cancer immunotherapy, CAR-T, clinical trial, CTL019, cytokine release syndrome, leukemia, research


FDA-approved drugs for relapsed acute lymphoblastic leukemia have remission rates under 25%; experimental therapeutic CAR T cells top that at 90%.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts